Two L1-peptides are excellent tools for serological detection of HPV-associated cervical carcinoma lesions

Biochemical and Biophysical Research Communications

Volumn 332, Issue 1, 2005, Pages 224-232

  Urquiza, Mauricio ^a,b   Guevara, Tatiana ^a,b   Espejo, Fabiola ^a,b   Bravo, Maria Mercedes ^c   Rivera, Zuly ^a   Patarroyo, Manuel E ^a,b  

^a FUNDACIÓN INSTITUTO DE INMUNOLOGÍA DE COLOMBIA FIDIC   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^c Instituto Nacional de Cancerología   (Colombia)

Author keywords

Cervical cancer; Cervical intraepithelial neoplasia; ELISA; HPV; HPV DNA; HPV patients; VLP

Indexed keywords

PEPTIDE DERIVATIVE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SERODIAGNOSIS; UTERINE CERVIX CARCINOMA; WART VIRUS;

ADOLESCENT; ADULT; CAPSID PROTEINS; FEMALE; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; REPRESSOR PROTEINS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 19344371583     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.115     Document Type: Article

References (38)

1. D.M. Parkin, P. Pisani, and J. Ferlay Global cancer statistics CA Cancer J. Clin. 49 1999 33 64
2. F.X. Bosch, A. Lorincz, N. Munoz, C.J. Meijer, and K.V. Shah The causal relation between human papillomavirus and cervical cancer J. Clin. Pathol. 55 2002 244 265
3. H. Zur Hausen papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis J. Natl. Cancer Inst. 92 2000 690 698
4. N. Munoz Human papillomavirus and cancer: the epidemiological evidence J. Clin. Virol. 19 2000 1 5
5. G.Y. Ho, R.D. Burk, S. Klein, A.S. Kadish, C.J. Chang, P. Palan, J. Basu, R. Tachezy, R. Lewis, and S. Romney Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia J. Natl. Cancer Inst. 87 1995 1365 1371
6. M. Moberg, I. Gustavsson, and U. Gyllensten Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ Int. J. Cancer 112 2004 854 859
7. M.S. Rajeevan, D.C. Swan, R. Nisenbaum, D.R. Lee, S.D. Vernon, M.T. Ruffin, I.R. Horowitz, L.C. Flowers, D. Kmak, T. Tadros, G. Birdsong, M. Husain, S. Srivastava, and E.R. Unger Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women Int. J. Cancer 115 2005 114 120
8. J. Cason, P.K. Kambo, J.M. Best, and D.J. McCance Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type-16 (HPV-16) in sera from patients with cervical intraepithelial neoplasia and children Int. J. Cancer 50 3 1992 349 355
9. J.C. Calvo, K.C. Choconta, D. Diaz, O. Orozco, M.M. Bravo, F. Espejo, L.M. Salazar, F. Guzmán, and M.E. Patarroyo An alpha helix conformationally restricted peptide is recognised by cervical carcinoma patient's sera J. Med. Chem. 46 2003 5389 5394
10. R.P. Viscidi, K.L. Kotloff, B. Clayman, K. Russ, S. Shapiro, and K.V. Shah Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women Clin. Diagn. Lab. Immunol. 4 1997 122 126
11. B. Nonnenmacher, N.L. Hubbert, R. Kirnbauer, K.V. Shah, N. Munoz, F.X. Bosch, S. de Sanjose, R. Viscidi, D.R. Lowy, and J.T. Schiller Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain J. Infect. Dis. 172 1995 19 24
12. R. Kirnbauer, N.L. Hubbert, C.M. Wheeler, T.M. Becker, D.R. Lowy, and J.T. Schiller A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16 J. Natl. Cancer Inst. 86 1994 494 499
13. P. Le Cann, A. Touze, N. Enogat, D. Leboulleux, C. Mougin, M.C. Legrand, C. Calvet, J.M. Afoutou, and P. Coursaget Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus J. Clin. Microbiol. 33 1995 1380 1382
14. J. Dillner, I. Kallings, C. Brihmer, B. Sikstrom, P. Koskela, M. Lehtinen, J.T. Schiller, M. Sapp, and P.A. Mardh Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior J. Infect. Dis. 173 1996 1394 1398
15. J.J. Carter, L.A. Koutsky, G.C. Wipf, N.D. Christensen, S.K. Lee, J. Kuypers, N. Kiviat, and D.A. Galloway The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women J. Infect. Dis. 174. 1996 927 936
16. T.D. de Gruijl, H.J. Bontkes, J.M. Walboomers, J.T. Schiller, M.J. Stukart, B.S. Groot, M.M. Chabaud, A.J. Remmink, R.H. Verheijen, T.J. Helmerhorst, C.J. Meijer, and R.J. Scheper Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia J. Natl. Cancer Inst. 89 1997 630 638
17. R.B. Roden, H.L. Greenstone, R. Kirnbauer, F.P. Booy, J. Jessie, D.R. Lowy, and J.T. Schiller In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype J. Virol. 70 1996 5875 5883
18. V. Af Geijersstam, M. Kibur, Z. Wang, P. Koskela, E. Pukkala, J. Schiller, M. Lehtinen, and J. Dillner Stability over time of serum antibody levels to human papillomavirus type 16 J. Infect. Dis. 177 1998 1710 1714
19. M.H. Schiffman, and P. Castle Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia J. Natl. Cancer Inst. 95 2003 E2
20. Y. van der Graaf, A. Molijn, H. Doornewaard, W. Quint, L.J. van Doorn, and J. vanden Tweel Human papillomavirus and the long-term risk of cervical neoplasia Am. J. Epidemiol. 156 2002 158 164
21. M.C. Rousseau, J.S. Pereira, J.C. Prado, L.L. Villa, T.E. Rohan, and E.L. Franco Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection J. Infect. Dis. 184 2001 1508 1517
22. E. Paraskevaidis, E.J. Davidson, V. Malamou-Mitsi, P.M. Hirsch, L. Pappa, G. Koliopoulos, E. Lolis, K. Zikopoulos, M. Paschopoulos, V. Doussias, and N. Agnantis An observational study of women with positive HPV-DNA tests and normal cytology and colposcopy Eur. J. Gynaecol. Oncol. 23 2002 320 322
23. K.L. Karem, A.C. Poon, C. Bierl, R. Nisenbaum, and E. Unger Optimization of a human papillomavirus-specific enzyme-linked immunosorbent assay Clin. Diagn. Lab. Immunol. 9 2002 577 582
24. L. Rocha-Zavaleta, J.P. Ambrosio, Mde. L. Mora-Garcia, F. Cruz-Talonia, J. Hernandez-Montes, B. Weiss-Steider, V. Ortiz-Navarrete, and A. Monroy-Garcia Detection of antibodies against a human papillomavirus (HPV) type 16 peptide that differentiate high-risk from low-risk HPV-associated low-grade squamous intraepithelial lesions J. Gen. Virol. 85 2004 2643 2650
25. X.S. Chen, R.L. Garcea, I. Goldberg, G. Casini, and S.C. Harrison Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16 Mol. Cell. 5 2000 557 567
26. R. Fraczkiewicz, W.A. Braun. New efficient algorithm for calculating solvent accessible surface areas of macromolecules, ECCC3; 1996; Northern Illinois University
27. K. Seedorf, T. Olterdorf, G. Krammer, and W. Rowekamp Identification of early proteins of the human papillomaviruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells EMBO J. 6 1987 139 144
28. R.A. Houghten Identification of early proteins of the human papillomaviruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells Proc. Natl. Acad. Sci. USA 82 1985 5131 5135
29. A. Touze, S. El Mehdaoui, P.Y. Sizaret, C. Mougin, N. Munoz, and P. Coursaget The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system J. Clin. Microbiol. 36 1998 2046 2051
30. M.V. Jacobs, A.M. de Roda Husman, A.J. van den Brule, P.J. Snijders, C.J. Meijer, and J.M. Walboomers Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes J. Clin. Microbiol. 33 1995 901 905
31. A.J. vanden Brule, C.J. Meijer, V. Bakels, P. Kenemans, and J.M. Walboomers Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction J. Clin. Microbiol. 28 1990 2739 2743
32. A.M. de Roda Husman, J.M. Walboomers, A.J. vanden Brule, C.J. Meijer, and P.J. Snijders The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR J. Gen. Virol. 76 1995 1057 1062
33. Y. Modis, B.L. Trus, and S.C. Harrison Atomic model of the papillomavirus capsid EMBO J. 21 2002 4754 4762
34. B.K. Sharma, A. Ray, and N.S. Murthy Prevalence of serum antibodies to synthetic peptides to HPV16 epitopes among Indian women with cervical neoplasia Eur. J. Cancer 32A 1996 872 876
35. H. Santamaria, K. Manoutcharian, L. Rocha, E. Gonzalez, G. Acero, T. Govezensky, L.I. Uribe, A. Olguin, J. Paniagua, and G. Gevorkian Identification of peptide sequences specific for serum antibodies from human papillomavirus-infected patients using phage display libraries Clin. Immunol. 101 2001 296 302
36. R. Vera-Bravo, M. Ocampo, M. Urquiza, J.E. Garcia, L.E. Rodriguez, A. Puentes, R. Lopez, H. Curtidor, J.E. Suarez, E. Torres, F. Guzman, D. Diaz, J. Cortes, M.M. Bravo, A.L. Combita, O. Orozco, and M.E. Patarroyo Human papillomavirus type 16 and 18 L1 protein peptide binding to VERO and HeLa cells inhibits their VLPs binding Int. J. Cancer 107 2003 416 424
37. N.D. Christensen, N.M. Cladel, C.A. Reed, L.R. Budgeon, M.E. Embers, D.M. Skulsky, W.L. McClements, S.W. Ludmerer, and K.U. Jansen Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types Virology 291 2001 324 334
38. H. Santamaria, K. Manoutcharian, L. Rocha, E. Gonzalez, G. Acero, T. Govezensky, L.I. Uribe, A. Olguin, J. Paniagua, and G. Gevorkian Identification of peptide sequences specific for serum antibodies from human papillomavirus-infected patients using phage display libraries Clin. Immunol. 101 2001 296 302